Elkhorn Partners Limited Partnership Gilead Sciences, Inc. Transaction History

Elkhorn Partners Limited Partnership

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$63.15 - $72.88 $296,805 - $342,536	4,700 Added 494.74%	5,650 $388,000
Q1 2024 May 16, 2024	SELL	$71.58 - $87.29 $182,529 - $222,589	-2,550 Reduced 72.86%	950 $70,000
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $225,477 - $274,963	3,150 Added 900.0%	3,500 $222,000
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $40,298 - $45,699	-550 Reduced 61.11%	350 $28,000
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $66,546 - $72,603	900 New	900 $67,000
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $59,163 - $66,635	-1,025 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$57.92 - $72.58 $59,368 - $74,394	1,025 New	1,025 $61,000
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $33,845 - $36,515	-500 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $28,325 - $32,275	500 New	500 $29,000
Q2 2020 Aug 13, 2020	SELL	$72.34 - $84.0 $9,042 - $10,500	-125 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $236,428 - $302,830	-3,775 Reduced 96.79%	125 $9,000
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $24,648 - $27,112	400 Added 11.43%	3,900 $253,000
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $216,545 - $242,829	3,500 New	3,500 $236,000
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $270,864 - $299,896	-3,800 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $246,543 - $287,584	3,800 New	3,800 $269,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Elkhorn Partners Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Elkhorn Partners Limited Partnership with notifications on news.